1. Kelly SE, Campbell D, Duhn LJ, et al. Remote monitoring of cardiovascular implantable
electronic devices in Canada: survey of patients and device healthcare professionals. CJC …

In 2010, both the American Heart Rhythm Society (AHRS) and European Heart Rhythm
Association (EHRA) released consensus statements on management of cardiovascular …

Background Implantable cardioverter-defibrillators (ICDs) cannot prevent death from
progressive heart failure or non-cardiac disease. Patients with ICDs may receive …

Cardiac implantable electrical devices (CIEDs), including pacemakers (PMs) and
implantable cardioverter-defibrillators (ICDs), are the most effective treatment for life …

Methods. We recruited ICD patients 50 years and older who were followed in a single
academic electrophysiology practice (Yale University). Eligible participants were English …

The purpose of this Consensus Statement is to focus on implantable cardioverter-
defibrillator (ICD) deactivation in patients with irreversible or terminal illness. This statement …

Advisories associated with implanted antiarrhythmia devices have been an invariable part of
the life of physicians monitoring such devices. 1, 2 Nonetheless, device advisories appear to …

Patients with substantial left ventricular scarring are prone to sudden death, presumably
from ventricular tachyarrhythmias (sustained ventricular tachycardia and ventricular …

On May 14, 2010, the Heart Rhythm Society issued a consensus statement on the
management of implantable cardiac devices (pacemakers and implantable cardioverter …

This chapter explores the commonly articulated concerns regarding the morality and legality
of deactivating CIEDs and MCSs, beginning with two case examples. The goal is to present …